Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents.

Hisashi ShigaTakahiro TakahashiManabu ShirakiYasuhiro KojimaTsuyotoshi TsujiSho TakagiKeiichiro HiramotoNaonobu YokoyamaMikako SugimuraMasahiro IwabuchiKatsuya EndoMotoyuki OnoderaYuichirou SatoYosuke ShimodairaEiki NomuraTatsuya KikuchiHirofumi ChibaShinya OomoriHisaaki KudoKazuki KumadaSatoshi NagaieSoichi OgishimaFuji NagamiYusuke ShimoyamaRintaro MoroiMasatake KurohaYoichi KakutaTakashi IshigeYoshitaka KinouchiAtsushi Masamune

Published in: Scandinavian journal of gastroenterology (2022)

IBD patients, especially those with UC, exhibit reduced seropositivity rates and may benefit from screening prior to the initiation of immunosuppressive therapy.

Keyphrases

patients with inflammatory bowel disease
newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
patient reported
cell therapy
smoking cessation